A bionic implant is an artificially engineered device that is implanted to replace a natural organ in a human, with the purpose to provide life support while awaiting a transplant and improves a patient’s ability to interact socially. According to the report published by Market Research Future (MRFR), the global medical bionic implant/artificial organs market is anticipated to grow exponentially and register a CAGR of 7.0% over the forecast period of 2018 to 2023.
The growing cases of organ failure have improved the demand for replaceable organs, which contributes to the market growth of the medical bionic implant/artificial organs market to a great extent. The prevalence of organ failure is found to be more common among the elderly consumers, as they are more vulnerable towards health issues such as gastrointestinal problems, ophthalmic diseases, cancer, orthopedic diseases, among others. Other influential factors such as technological advancements, a growing number of accidents and injuries, improving the government regulatory framework and assistance, and the increasing prevalence of eye diseases are constantly contributing to create growth in the global medical bionic implant/artificial organs market.
To Get Free Sample Copy of Report visit https://www.marketresearchfuture.com/sample_request/6051
Despite these positive factors, issues connected with the medical bionic implant/artificial organs market are lack of skilled professionals, the high expenditure on devices, risk of malfunction of devices, and the comparatively poor healthcare system in low and middle-income countries may obstruct the growth of the market to an extent.
Key Players:
The key market players in the Global Medical Bionic Implant/Artificial Organs Market are,
- Biomet, Inc. (U.S.),
- NeuroPace, Inc. (U.S.),
- Boston Scientific Corporation (U.S.),
- St. Jude Medical, Inc. (U.S.)
- Cyberonics, Inc. (U.S.),
- Medtronic, Inc. (U.S.),
- Ekso Bionics (U.S.),
- Second Sight Medical Products, Inc. (U.S.),
- Aleva Neurotherapeutics SA (Switzerland),
- LivaNova PLC (U.K),
- Orthofix International N.V. (The Netherlands),
- Ossur (Iceland), Biocontrol Medical (Israel), and
- Cochlear Ltd. (Australia).
Segments:
The Global Medical Bionic Implant/Artificial Organs Market is segmented on the basis of technology, product, fixation, and end-user.
On the basis of technology, the market is classified as mechanical bionics and electronic bionics.
By product, the market is classified as vision bionics, ear bionics, orthopedic bionics, heart bionics, neural/brain bionics, and others. Vision bionics are further segmented as bionic eye and others. Ear bionics are further segmented as cochlear implant and Bone Anchored Hearing Aid (BAHA). Orthopedic bionics are further segmented as bionic hand, bionic leg, bionic finger, exoskeleton, and electrical bone growth stimulators. The sub-segments of bionic leg include bionic knee and bionic feet. The sub-segments of electrical bone growth stimulators include invasive bone growth stimulators and non-invasive bone growth stimulators. Heart bionics are further segmented as pacemaker, total artificial heart, ventricular assist device, and artificial heart valve. The sub-segments of pacemaker include implantable cardiac pacemaker and external pacemaker. The sub-segments of artificial heart valve include mechanical heart valve and tissue heart valve. Neural/brain bionics are further segmented as deep brain stimulators, vagus nerve stimulator, and spinal cord stimulators.
By fixation, the market is segmented into implantable and externally worn.
By end-user, the market is segmented into hospitals and clinics, research and academic institutes, and others.
Regional Analysis:
North America dominates the regional market for medical bionic implant/artificial organs due to the presence of major market players who have introduced advanced medical bionic implants.
Europe is the second largest region in the global medical bionic implant/artificial organs market, owing to the government aid towards research and development expenditure, and the rising cases of organ failure and connected difficulties, and are expected to drive the European market.
The Asia Pacific is assessed as the fastest growing medical bionic implant/artificial organs market owing to increasing demand for advanced treatments, a huge patient pool, and development in the healthcare technology. Healthcare expenditure is found to be improving in various Asia Pacific regions.
The Middle East & Africa hold the lowest share of the global market due to low development, poor medical facilities, and lack of technical knowledge.
To Browse Complete Report visit https://www.marketresearchfuture.com/reports/medical-bionic-implant-artificial-organs-market-6051
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Statistical Report, Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com/reports/medical-bionic-implant-artificial-organs-market-6051